NASDAQ
12.10.26 | 22:00
7,250 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Profound Medical Reports Q2 2026 Results: Full Earnings Call Transcript | 2 | Benzinga.com | ||
| Fr | Profound Medical Corp (2): Profound Medical, Telix sign prostate care deal | 3 | Stockwatch | ||
| Fr | Profound Medical, Telix Pharma Sign Co-Education Deal To Advance PSMA-Informed Prostate Care | 334 | AFX News | CANBERA (dpa-AFX) - Friday, Profound Medical Corp. (PROF) and Telix Pharmaceuticals Limited (TLX) announced a co-education agreement to educate physicians and prostate cancer centers on the... ► Artikel lesen | |
| Fr | Profound Medical und Telix vereinbaren Bildungskooperation für Ärzte | 5 | Investing.com Deutsch | ||
| PROFOUND MEDICAL Aktie jetzt für 0€ handeln | |||||
| Fr | Profound Medical Corp.: Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care | 194 | GlobeNewswire (Europe) | Collaboration will educate physicians and prostate cancer centers on the complementary roles of Telix's PSMA-PET molecular imaging technologies and Profound's MRI-guided TULSA-PRO- Agreement provides... ► Artikel lesen | |
| Do | Profound Medical: Raymond James bestätigt "Strong Buy" und sieht deutliches Kurspotenzial | - | Investing.com Deutsch | ||
| Do | Raymond James reiterates Strong Buy on Profound Medical stock, $11 target | 1 | Investing.com | ||
| Do | Profound Medical Corp (2): Profound Medical releases preliminary Q3 results | 1 | Stockwatch | ||
| Mi | Profound Medical-Aktie schießt nach angehobener Umsatzprognose um 20 % in die Höhe | 1 | Investing.com Deutsch | ||
| Mi | Profound Medical: Aktie schießt nach überraschend starker Umsatzprognose in die Höhe | - | Investing.com Deutsch | ||
| Mi | Profound Medical Corp. - 8-K, Current Report | 1 | SEC Filings | ||
| Mi | Profound Medical expects Q3 revenue could top estimates by 47% | 1 | Seeking Alpha | ||
| Mi | Profound Medical erwartet Umsatzsprung von bis zu 89 % im dritten Quartal | 2 | Investing.com Deutsch | ||
| Mi | Profound Medical anticipates Q3 revenue up to 89% year-over-year | 1 | Investing.com | ||
| Mi | Profound Medical Corp.: Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue | 102 | GlobeNewswire (Europe) | TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets innovative... ► Artikel lesen | |
| 03.09. | Profound Medical Corp. - 8-K, Current Report | 2 | SEC Filings | ||
| 01.09. | Profound Medical Corp (2): Profound Medical appoints Fabian as president | 3 | Stockwatch | ||
| 18.08. | Profound Medical Corp (2): Profound introduces software for six Tulsa procedures | 1 | Stockwatch | ||
| 17.08. | Profound Medical Corp.: Profound's Introduction of New Real-time Interventional MRI Software Paving the Way for Full 'TULSA Days' | 1 | GlobeNewswire (USA) | ||
| 15.08. | Profound Medical Corp (2): Profound Medical appoints Sobczyk interim CFO | 1 | Stockwatch |
1 2 3 Weiter >>
50 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| TELADOC HEALTH | 5,350 | +0,72 % | Teladoc Health Adds Contactless Vitals and Ambient AI Scribe to Virtual Visit Platform | ||
| SERNOVA BIOTHERAPEUTICS | 0,063 | -5,09 % | Sernova Biotherapeutics Inc ÜBERRASCHT Anleger: Meine brandneue Prognose ändert einfach alles - Dringend vor Börsenschluss handeln! | ||
| CERENOME | 1,616 | +7,45 % | Cerenome, Inc.: Cerenome Launches CNSide CSF Molecular Profile Tests | HOUSTON, Oct. 06, 2026 (GLOBE NEWSWIRE) -- CNSide Diagnostics, LLC, a wholly owned subsidiary of Cerenome, Inc. (Nasdaq: CNSY) ("Cerenome" or the "Company"), today announced the commercial launch... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 2,160 | +0,93 % | Atossa Therapeutics schließt CVR-Vereinbarung für Erlöse aus FDA-Prüfgutschein | ||
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc. - 8-A12B/A, Registration of securities | ||
| TANDEM DIABETES | 14,800 | 0,00 % | Tandem Diabetes Care Q2 2026 Earnings Call Transcript | ||
| CO-DIAGNOSTICS | 1,250 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| QUIDELORTHO | 12,000 | +1,14 % | Sanjeev Sharma wird neuer Leiter Investor Relations bei QuidelOrtho | ||
| VERU | 2,415 | +0,42 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -5- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameUS75973T2006 RENALYTIX... ► Artikel lesen | |
| LIFEWARD | 6,360 | +1,92 % | Lifeward Ltd. - 8-K, Current Report | ||
| CLOVER HEALTH INVESTMENTS | 4,370 | +2,10 % | Why Is Clover Health (CLOV) Stock Soaring Today | ||
| SENSEONICS | 8,300 | 0,00 % | Senseonics Holdings Q2 2026 Earnings Call: Complete Transcript | ||
| TEMPEST THERAPEUTICS | 0,740 | -0,35 % | Tempest Therapeutics beruft Nancy Freda-Smith in den Verwaltungsrat | ||
| NANO-X IMAGING | 0,508 | -0,39 % | Nano-X Imaging Ltd: Nanox Expands Latin American Presence with Nanox.ARC Distribution Agreement in Costa Rica | Agreement with SOLME RC, SA Marks the third Latin American market this year PETACH TIKVA, Israel, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Nanox Imaging Ltd. (NASDAQ: NNOX) ("Nanox"), a leader in innovative... ► Artikel lesen | |
| IMUNON | 0,950 | -0,52 % | Imunon, Inc.: IMUNON Reports Strong Enrollment Momentum in Phase 3 OVATION 3 Trial of IMNN-001 in Advanced Ovarian Cancer | Enrollment momentum exceeding expectations is based on highly promising survival (OS) data and well tolerated safety profile demonstrated in the Company's large, randomized Phase II study, OVATION... ► Artikel lesen |
Das Unternehmen PROFOUND MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 7,250 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PROFOUND MEDICAL CORP finden Sie auf Wallstreet Online.